Thesis TrackerLoading companies…
All companies
Loading…
Thesis TrackerThesis TrackerLoading…
Alcidion (ASX:ALC) is a hospital software company that Cyan Investment Management regards as one of its highest-conviction holdings. In August 2026, Cyan said full-year results reinforced its confidence, with record revenue growth of 27% and EBITDA of $6.2 million ahead of expectations. Tamim Funds Management highlighted record fourth-quarter operating cash flow of $7.7 million and $43 million of new contract value, led by a seven-year electronic patient record agreement with University Hospitals Sussex in the UK. Alcidion operates in the Healthcare sector within the Health Care Technology industry, and Thesis Tracker has captured 35 comments from 4 fund managers, including Cyan Investment Management and Tamim Funds Management. Alcidion develops and licenses healthcare software, including its Miya Precision platform for patient flow, clinical observations and patient administration, used by hospitals in Australia, New Zealand and the United Kingdom.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Cyan Investment Management, Salter Brothers, Elston Asset Management and Tamim Funds Management have invested in Alcidion Group Ltd (ASX:ALC).
Managers highlight record revenue, operating cash flow and EBITDA, and major contract wins including the University Hospitals Sussex deal worth up to $49 million with an upfront payment. Cyan expects further material contracts to land and sees growing investor recognition of the company's turnaround.
Cyan noted the share price fell 16% in a single month despite record quarterly results, showing volatility, and growth depends on winning large, lumpy hospital software contracts whose timing is difficult to predict.
Alcidion Group Limited (ALC) develops and licenses healthcare software, including the Miya Precision platform and its modules: Miya Observations, Flow, Task Management, and PAS. The company resells partner healthcare software and provides implementation, support, maintenance, systems integration, and data analysis services. Alcidion serves healthcare customers across Australia, New Zealand, and the United Kingdom.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.